37.1
Annovis Bio, Inc.
Metrics score locked — part of Premium
FY22
FY22
FY23
FY24
FY25
FY22 – FY25
Assets
(positive)
Change from FY22 to FY25
millions USD
FY22:
FY22:
36.0
FY23:
10.2
FY24:
13.9
FY25:
21.1
(positive)
millions USD
FY22:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
Total assets
Change from FY22 to FY25
millions USD
FY22:
37.1
FY22:
36.0
FY23:
10.2
FY24:
13.9
FY25:
21.1
Liabilities & Equity
(negative)
Change from FY22 to FY25
millions USD
FY22:
2.53
FY22:
7.70
FY23:
4.28
FY24:
3.88
FY25:
3.64
(negative)
millions USD
FY22:
0
FY22:
0
FY23:
13.7
FY24:
0.74
FY25:
0.60
(positive)
Change from FY22 to FY25
millions USD
FY22:
34.6
FY22:
28.3
FY23:
−7.75
FY24:
9.31
FY25:
16.9
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
37.1
FY22:
36.0
FY23:
10.2
FY24:
13.9
FY25:
21.1
All amounts in millions USD